
QuickMD Review
Semaglutide GLP-1 weight-loss telehealth · Independently scored 7.4/10
Best for: Cost-conscious patients wanting same-day compounded or brand GLP-1 access
QuickMD is a solid telehealth option with balanced features and pricing.
No insurance needed · Vetted by our editors
QuickMD is a high-volume telemedicine platform (over 1 million visits) offering same-day online weight-management care. It provides compounded semaglutide for about $279 per month and can prescribe brand-name GLP-1s including Wegovy, Zepbound, Ozempic, Mounjaro and oral Rybelsus, with medication costs varying by pharmacy. Visits are conducted entirely online by phone or video with licensed clinicians, available 365 days a year in 45-plus states. QuickMD uses transparent cash-pay pricing and does not bill insurance, though it provides visit summaries for possible reimbursement.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to QuickMD
Sunlight
Best for: compounded GLP-1 with unlimited telehealth visits and free shipping
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
QuickMD at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $279/mo
- FDA status
- No FDA warning letter on record
How we scored QuickMD
Each dimension is scored algorithmically from QuickMD’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.1/10At $279/mo, QuickMD runs about 65% above the $170 median for GLP-1 providers.
Effectiveness25%
8.4/10QuickMD offers semaglutide, the GLP-1 with the deepest published weight-loss evidence base.
User Experience15%
8.0/10Online intake and platform experience; 8 platform features disclosed.
Trust & Safety15%
7.8/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-06).
Accessibility10%
6.9/10QuickMD's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.7/10QuickMD provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this QuickMD review
Last checked July 2026- Confirmed current pricing across 1 dose/plan tier
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with QuickMD
We walked QuickMD’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Answer questions about what you're looking for; the site shows matching doctors.
- 2Choose an available provider in your state and book an appointment time.
- 3Before the appointment: verify ID, complete the intake form, and use the app or browser.
- 4Connect with the doctor by private phone or online video call.
- $99/consultation is shown, but no monthly medication price is published ('price does not include cost of medication').
- A real-time doctor visit (phone or video) is required.
- No membership required; cash-pay, no insurance.
- Offers tirzepatide (Mounjaro/Zepbound) and semaglutide (Wegovy/Ozempic/Rybelsus).
GLP-1 medications QuickMD offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often — check QuickMD's current pricing and active discounts before you decide.
What we like
- Compounded semaglutide around $279/mo plus brand-name GLP-1 options
- Same-day, 365-day-a-year online visits
- Large established platform with over 1 million completed visits
- Transparent cash-pay pricing with reimbursement summaries
- Can prescribe Wegovy, Zepbound, Ozempic, Mounjaro, Rybelsus
Watch-outs
- Does not accept insurance
- Available in 45+ states, not all 50
- Medication cost varies by pharmacy, not fully bundled
- No named board-certified physicians listed publicly
QuickMD: a high-volume telehealth platform built around the visit, not a medication bundle
QuickMD is not a boutique weight-loss brand. It is a large, general telemedicine platform that has logged more than a million completed visits across many kinds of care, and weight management is one lane inside that bigger operation. That scale is the first thing worth understanding about it. You are buying access to a same-day clinician on a system that runs every day of the year, in 45-plus states, entirely by phone or video. If your priority is getting in front of a licensed prescriber quickly and getting a semaglutide prescription written, QuickMD is built for exactly that. If your priority is a tidy all-in monthly price with the medication included in the box, this is not that kind of service, and you should know that going in.
How the money actually works here (and a pricing change to know about)
QuickMD's current model is a consult-fee model, not a subscription. You pay a flat fee for a weight-loss consultation with a licensed doctor who assesses you and, if it's appropriate, writes a GLP-1 prescription. The fee sits in the low three figures per visit. The medication itself is billed separately, and its cost depends entirely on which pharmacy fills the script and what, if any, drug coverage you have. There is no membership, no recurring platform charge, and the company is explicit that there are no surprise fees layered on top of the visit.
One honest caveat on price: our listing has carried a compounded semaglutide program at roughly $279 a month, but when we last checked QuickMD's own pricing page, that bundle was no longer shown — the page now leads with the per-consultation fee and states that medication cost is whatever your pharmacy charges. So treat the $279 figure as a historical reference point rather than a guaranteed live rate, and confirm the current numbers directly before you commit. For comparison, the category median across providers we track runs around $170 a month, so a compounded route through QuickMD could land below that — but only if you can source affordable compounded semaglutide, which the platform no longer appears to wrap into a fixed price.
The medications: brand GLP-1s plus a compounded option, dispensed through outside pharmacies
This is one of QuickMD's genuine strengths. Its clinicians can prescribe the full slate of brand-name GLP-1s — Wegovy, Zepbound, Ozempic, Mounjaro — as well as oral Rybelsus, and they can also write for compounded semaglutide. Many cash-pay weight-loss services funnel everyone toward a single compounded formulation because that's what they bundle and profit from. QuickMD instead writes the prescription and lets you fill it where it makes sense for you. That flexibility matters if your insurance happens to cover a brand drug, or if you specifically want a brand pen rather than a compounded vial.
The trade-off is the flip side of that same coin: because the drug is filled by an outside pharmacy, your real monthly cost is unpredictable until you actually price the prescription. A brand GLP-1 without coverage can run well over a thousand dollars a month at retail; the same drug with good coverage can be a modest copay. QuickMD gives you the script and a visit summary you can submit for possible reimbursement, but it does not bill insurance itself, and it cannot promise you a price on a medication it isn't dispensing.
What genuinely sets QuickMD apart
The real differentiator is speed and reach backed by a track record. Same-day visits, 365 days a year, on a platform that has handled over a million encounters and reports very high patient satisfaction, is a meaningfully different proposition from a newer startup. You are unlikely to wait days for an appointment, and you're not depending on a single small clinic's hours. For people who want to start a GLP-1 conversation today, that responsiveness is the headline feature — more than any single price.
- Same-day, phone-or-video visits available every day of the year
- Prescribes brand GLP-1s (Wegovy, Zepbound, Ozempic, Mounjaro), oral Rybelsus, and compounded semaglutide
- Transparent flat consult fee with no membership and no recurring platform charge
- Provides itemized visit summaries you can submit for possible insurance reimbursement
- Established platform with 1M-plus completed visits across its telehealth services
Who should choose it — and who should skip it
Choose QuickMD if you want fast, low-commitment access to a prescriber, you're comfortable filling your medication at an outside pharmacy, and you value being able to get a brand-name GLP-1 rather than only a house compounded formula. It's a sensible fit for someone who already has some drug coverage, or who wants a clinician's prescription without locking into a monthly program.
Skip it if you want one predictable number that covers everything. Because the medication is priced by your pharmacy, your total monthly spend can swing widely, and budgeting is harder than it is with a fully bundled competitor. Skip it too if you live in one of the states QuickMD doesn't yet serve — it's in 45-plus states, not all 50 — or if having insurance billed directly is important to you, since this is strictly cash-pay.
Trust, safety and medical oversight
On the reassuring side, there are no FDA warning letters on file for QuickMD in our records, and visits are conducted by licensed clinicians on a long-running, high-volume platform — the kind of operating history that's hard to fake. On the cautious side, QuickMD does not publish the names or credentials of specific board-certified physicians leading its weight program, and it doesn't enumerate its exact state list publicly, which is why we hold our verification confidence at a medium rather than high level. None of that is a red flag, but it does mean you're trusting the platform's process more than a named medical director. As always, weigh this against your own situation and read our scoring methodology for how we grade these factors.
Bottom line
QuickMD is a fast, flexible, cash-pay front door to GLP-1 treatment, strongest for people who want a quick prescription and the freedom to fill a brand or compounded drug at their own pharmacy. Its weakness is cost predictability: with the medication priced outside the visit — and the older compounded bundle near $279 apparently no longer offered — your true monthly outlay depends on your pharmacy and coverage, not on QuickMD. Go in expecting to pay a flat consult fee and then to shop your prescription, confirm the current pricing yourself, and it's a solid, no-strings option. Want everything wrapped into one fixed monthly price? A fully bundled competitor will suit you better.
If you're weighing alternatives, Direct Meds ($249/month) and MyStart Health ($299/month) are among the closest options we track to QuickMD.
The Bottom Line
QuickMD is a solid telehealth option with balanced features and pricing.
Ready to start with QuickMD?
Starting at $279/month. See current pricing and start your free consultation.
QuickMD might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this QuickMD review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
See QuickMD's current pricing
Plans start at $279/month. Start your free consultation to check eligibility and today's price.